≡

ELISA Kit for Bone Morphogenetic Protein 15 (BMP15)

GDF9B; GDF9-B; ODG2; POF4; Growth/differentiation factor 9B

Specificity

This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 15 (BMP15).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 15 (BMP15) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 15 (BMP15) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 15 (BMP15) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-95 92
EDTA plasma(n=5) 96-103 101
heparin plasma(n=5) 81-94 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 15 (BMP15) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 15 (BMP15) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 15 (BMP15) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-101% 95-103% 91-98% 98-105%
EDTA plasma(n=5) 97-104% 88-96% 84-95% 86-99%
heparin plasma(n=5) 80-92% 91-101% 78-102% 89-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Ovarian Research Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial Pubmed:25330837
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC107Hu01 Recombinant Bone Morphogenetic Protein 15 (BMP15) Positive Control; Immunogen; SDS-PAGE; WB.
PAC107Hu01 Polyclonal Antibody to Bone Morphogenetic Protein 15 (BMP15) WB; IHC; ICC; IP.
MAC107Hu22 Monoclonal Antibody to Bone Morphogenetic Protein 15 (BMP15) WB; IHC; ICC; IP.
SEC107Hu ELISA Kit for Bone Morphogenetic Protein 15 (BMP15) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC107Hu Multiplex Assay Kit for Bone Morphogenetic Protein 15 (BMP15) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.